Oxaliplatin Kabi 5 mg/ml koncentrat za otopinu za infuziju [paralelni uvoz]
| Name | Oxaliplatin Kabi 5 mg/ml koncentrat za otopinu za infuziju [paralelni uvoz] |
|---|---|
| Marketing Authorisation Number | HR-H-004755819 |
| Active Substance | oksaliplatin |
| Composition | 1 ml koncentrata za otopinu za infuziju sadrži 5 mg oksaliplatina |
| Pharmaceutical Form | Koncentrat za otopinu za infuziju |
| Manufacturer | Proizvođač odgovoran za prepakiranje: Cefea Sp. z o.o. Sp. komandytowa, Varšava, Poljska
Proizvođač odgovoran za puštanje lijeka u promet: Kabi Deutschland GmbH, Friedberg, Njemačka |
| Marketing Authorisation Holder | Delecto Firmus d.o.o., Kutnjački put 18, Zagreb, Hrvatska |
| Marketing Authorisation Date | 03.03.2022 |
| MA Period of Validity | 03.03.2027 |
| Classification Number | UP/I-530-01/21-12/02 |
| Registration Number | 381-12-01/14-22-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01XA03 |
| SmPC | download |
| PL | download |
